These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2230471)

  • 41. [The effective half-life of 131I during the treatment of autonomous thyroid disease with radioiodine].
    Müller B; Bares R; Büll U
    Nuklearmedizin; 1991 Jun; 30(3):71-6. PubMed ID: 1714566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Differentiated cancer of the thyroid. Prognostic factors and therapeutic attitude].
    Almou M; Alaoui M; Mokhtari M; el Alaoui M; Mansouri A
    Acta Chir Belg; 1989; 89(5):271-5. PubMed ID: 2816209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer.
    Johansen K; Woodhouse NJ; Odugbesan O
    J Nucl Med; 1991 Feb; 32(2):252-4. PubMed ID: 1992028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The current management of thyroid tumors in childhood.
    Newman KD
    Semin Pediatr Surg; 1993 Feb; 2(1):69-74. PubMed ID: 8062024
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The medullary (C-cell) carcinoma of the thyroid. A therapeutic dilemma].
    Schumann J; Hauk H; Leonhardi B
    Chirurg; 1977 Oct; 48(10):666-70. PubMed ID: 913180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Therapeutic approach to differentiated carcinoma of the thyroid gland].
    Busnardo B
    Minerva Endocrinol; 1987; 12(1):69-73. PubMed ID: 3587203
    [No Abstract]   [Full Text] [Related]  

  • 47. [Therapeutic management of thyroid cancer with remote metastases (experience with 34 operated cases)].
    Stoenescu D; Damian A; Oproiu A; Handoca A; Cernăianu N
    Endocrinologie; 1978; 16(2):89-96. PubMed ID: 675132
    [No Abstract]   [Full Text] [Related]  

  • 48. [Therapy of medullary thyroid carcinoma].
    Raue F
    Dtsch Med Wochenschr; 1985 Aug; 110(35):1337-9. PubMed ID: 2992904
    [No Abstract]   [Full Text] [Related]  

  • 49. [The treatment of differentiated thyroid cancer].
    Hubold C; Buchmann I; Lehnert H
    Dtsch Med Wochenschr; 2011 Apr; 136(17):891-5. PubMed ID: 21523640
    [No Abstract]   [Full Text] [Related]  

  • 50. [Therapy of thyroid neoplasms. Synopsis of guideline from section thyroid gland of the Deutsche Gesellschaft for Endokrinologie].
    Klein E; Heinze HG; Hoffmann G; Reinwein D; Schneider C
    Dtsch Med Wochenschr; 1976 May; 101(21):835-9. PubMed ID: 1269413
    [No Abstract]   [Full Text] [Related]  

  • 51. [On the importance of supplementary hormone treatment in radioiodine terapy of malignant thyroid gland tumors].
    Pabst HW; Heinze HG; Frey KW; Hör G
    Nucl Med (Stuttg); 1965; 2():389-95. PubMed ID: 5888970
    [No Abstract]   [Full Text] [Related]  

  • 52. New frontiers and treatment paradigms for thyroid carcinoma.
    Haddad R; Sherman SI; Shah JP; Wirth LJ
    Clin Adv Hematol Oncol; 2014 Jul; 12(7 Suppl 14):3-21; quiz 22. PubMed ID: 25768715
    [No Abstract]   [Full Text] [Related]  

  • 53. Epithelial cell thyroid cancer and thyroid stimulating hormone--when less is more.
    Emerson CH; Colzani R; Braverman LE
    J Clin Endocrinol Metab; 1997 Jan; 82(1):9-10. PubMed ID: 8989222
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of metastatic thyroid cancer.
    Leeper RD; Shimaoka K
    Clin Endocrinol Metab; 1980 Jul; 9(2):383-404. PubMed ID: 6994947
    [No Abstract]   [Full Text] [Related]  

  • 55. Definition and management of radioactive iodine-refractory differentiated thyroid cancer.
    Schlumberger M; Brose M; Elisei R; Leboulleux S; Luster M; Pitoia F; Pacini F
    Lancet Diabetes Endocrinol; 2014 May; 2(5):356-8. PubMed ID: 24795243
    [No Abstract]   [Full Text] [Related]  

  • 56. [Progress in medicine in separate presentations, LIV. Thyroid neoplasms].
    Kokoschka R; Depisch D; Roka R
    Wien Klin Wochenschr; 1979 Sep; 91(18):599-605. PubMed ID: 90433
    [No Abstract]   [Full Text] [Related]  

  • 57. Approaches to the treatment of high-risk thyroid cancer.
    Robbins J
    Thyroid; 1994; 4(3):385-7. PubMed ID: 7833681
    [No Abstract]   [Full Text] [Related]  

  • 58. [Diagnosis and treatment in thyroid malignancies].
    Shimizu K; Kitamura Y; Kitagawa W; Akasu H; Ishii R; Tanaka S
    J Nippon Med Sch; 2000 Apr; 67(2):134-8. PubMed ID: 10754604
    [No Abstract]   [Full Text] [Related]  

  • 59. Mediastinal uptake of 131-I in patients with thyroid cancer: may it be referred to normal thymus?
    Bestagno M; Pagliaini R; Maira G; Pizzocaro C
    Eur J Nucl Med; 1993 Jul; 20(7):648. PubMed ID: 8267738
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical picture and therapy of rare malignant tumors of the thyroid gland].
    Neĭmark II; Timoshnikov VM
    Probl Endokrinol (Mosk); 1967; 13(6):15-20. PubMed ID: 5620150
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.